Tech Company Financing Transactions
Neumentum Funding Round
Private investors participated in a $1.1 million capital raise for Neumentum. The round was announced on 3/28/2019.
Transaction Overview
Company Name
Announced On
3/28/2019
Transaction Type
Debt
Amount
$1,050,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 9 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
39 Eagle Nest Rd.
Morristown, NJ 07960
USA
Morristown, NJ 07960
USA
Phone
Website
Email Address
Not Recorded
Overview
Neumentum is dedicated to becoming a leading non-opioid analgesic and neurology specialty pharmaceutical company. More than 100 million Americans suffer from pain and many patients experiencing moderate to severe pain receive prescription opioids. Treatment with opioids comes with inherent risks.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Scott Shively
Chief Medical Officer
Ilona Steigerwald
Chief Scientific Officer
Robert Raffa
VP - Bus. Development
Sarah Faust
Browse more venture capital transactions:
Prev: 3/28/2019: MotoRefi venture capital transaction
Next: 3/29/2019: Trellis Research venture capital transaction
Share this article
About Database of VC Transactions
We do our best to record every notable VC transaction. VC transactions reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs